PF-07921585 is under clinical development by Pfizer and currently in Phase I for Metastatic Colorectal Cancer.

Bempikibart (ADX-914) is under development for the treatment of atopic dermatitis and alopecia areata. It is administered through subcutaneous route and acts by targeting interleukin-7 receptor (IL-7R ...

which will allow officials to meet with counterparts at departments and agencies ahead of the January transition of power. Pushpa 2 box office Day 13: Allu Arjun's film remains unstoppable People ...